Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Jenkins

Showing results (671-680 of 799) with videos related to

Pageof 80
Sort By:
JCO Precision Oncology|February 15, 2019
Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate CancerDeli Liu, Mandeep Takhar, Mohammed Alshalalfa, et al.
European Urology|May 13, 2015
Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypesScott A Tomlins, Mohammed Alshalalfa, Elai Davicioni, et al.
Blood Cancer Journal|February 10, 2021
Myeloid malignancies with 5q and 7q deletions are associated with extreme genomic complexity, biallelic TP53 variants, and very poor prognosisBeth A Pitel, Neeraj Sharma, Cinthya Zepeda-Mendoza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2018
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused UpdateAntonio C Wolff, M Elizabeth Hale Hammond, Kimberly H Allison, et al.
Archives of Pathology & Laboratory Medicine|May 31, 2018
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused UpdateAntonio C Wolff, M Elizabeth Hale Hammond, Kimberly H Allison, et al.
The Prostate|January 16, 2016
AXIN2 expression predicts prostate cancer recurrence and regulates invasion and tumor growthBrian R Hu, Adrian S Fairey, Anisha Madhav, et al.
Cancer Genetics|February 7, 2018
SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq)Sarah H Johnson, James B Smadbeck, Stephanie A Smoley, et al.
Neuro-Oncology|July 6, 2019
The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patientsCraig Horbinski, Keith L Ligon, Priscilla Brastianos, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Chromosome-arm-specific telomere length governs dual modes of structural genome evolution in IDH-mutant astrocytomaMaryam Jehangir, Kristen L Drucker, Ayse Keskus, et al.
Cancer Research|November 4, 2015
A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal EvolutionKyle M Walsh, Adam J de Smith, Helen M Hansen, et al.
Pageof 80

Showing results (671-680 of 799) with videos related to

Sort By:
Pageof 80
JCO Precision Oncology|February 15, 2019
Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate CancerDeli Liu, Mandeep Takhar, Mohammed Alshalalfa, et al.
European Urology|May 13, 2015
Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypesScott A Tomlins, Mohammed Alshalalfa, Elai Davicioni, et al.
Blood Cancer Journal|February 10, 2021
Myeloid malignancies with 5q and 7q deletions are associated with extreme genomic complexity, biallelic TP53 variants, and very poor prognosisBeth A Pitel, Neeraj Sharma, Cinthya Zepeda-Mendoza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2018
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused UpdateAntonio C Wolff, M Elizabeth Hale Hammond, Kimberly H Allison, et al.
Archives of Pathology & Laboratory Medicine|May 31, 2018
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused UpdateAntonio C Wolff, M Elizabeth Hale Hammond, Kimberly H Allison, et al.
The Prostate|January 16, 2016
AXIN2 expression predicts prostate cancer recurrence and regulates invasion and tumor growthBrian R Hu, Adrian S Fairey, Anisha Madhav, et al.
Cancer Genetics|February 7, 2018
SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq)Sarah H Johnson, James B Smadbeck, Stephanie A Smoley, et al.
Neuro-Oncology|July 6, 2019
The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patientsCraig Horbinski, Keith L Ligon, Priscilla Brastianos, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Chromosome-arm-specific telomere length governs dual modes of structural genome evolution in IDH-mutant astrocytomaMaryam Jehangir, Kristen L Drucker, Ayse Keskus, et al.
Cancer Research|November 4, 2015
A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal EvolutionKyle M Walsh, Adam J de Smith, Helen M Hansen, et al.
Pageof 80